Viewing Study NCT04681768


Ignite Creation Date: 2025-12-24 @ 5:45 PM
Ignite Modification Date: 2026-02-05 @ 8:47 PM
Study NCT ID: NCT04681768
Status: COMPLETED
Last Update Posted: 2025-09-26
First Post: 2020-12-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients
Sponsor:
Organization: